Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1448431/000121390018014379/f8k102318_optimizerx.htm
Exhibit 99.1
OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ET
ROCHESTER, Mich., (October 23, 2018) — OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Monday, November 5, 2018 at 4:30 p.m. Eastern time to discuss results for the third quarter ended September 30, 2018. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question and answer period.
Date: Monday, November 5, 2018
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Toll-free dial-in number: 1-888-221-3881
International dial-in number: 1-323-794-2591
Conference ID: 1275447
Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566.
A replay of the call will be available after 7:30 p.m. Eastern time on the same day through November 26, 2018, as well as available for replay via the Investors section of the OptimizeRx website at www.optimizerx.com.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1275447
About
OptimizeRx
OptimizeRx® (NASDAQ: OPRX) is one of the nation’s
leading providers of digital health messaging via electronic health records (EHRs), providing a direct channel for pharma companies
to communicate with healthcare providers. The company’s cloud-based solution supports patient adherence to medications by
providing real-time access to financial assistance, prior authorization, education, and critical clinical information. The company’s
network is comprised of leading EHR platforms like Allscripts, Amazing Charts and Quest, and provides more than half of the ambulatory
patient market with access to these benefits within their workflow at the point-of-care. For more information, follow the company
on Twitter, LinkedIn or visit www.optimizerx.com.
1
Important
Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be
used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or
revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements
are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual
results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks
and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation,
competition and other material risks.
OptimizeRx Contact
Doug Baker, CFO
Tel (248) 651-6568 x807
dbaker@optimizerx.com
Media Relations Contact
Nicole Brooks, Innsena Communications
(Tel) 860-800-2344
nicolebrooks@innsena.com
Investor Relations Contact
Ron Both, CMA
Tel (949) 432-7557
oprx@cma.team
2
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Optimizerx Corp.
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1448431/000121390018014379/f8k102318_optimizerx.htm
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1448431/000121390018014379/f8k102318ex99-1_optimizerx.htm
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1448431/000121390018014379/f8k102318_optimizerx.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years